Stockreport

ProKidney to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]

ProKidney Corp. - Class A Ordinary Shares  (PROK) 
PDF cell therapy company focused on chronic kidney disease (CKD), today announced that ProKidney's CEO, Bruce Culleton, M.D., will present at the 44 th Annual J.P. Morgan He [Read more]